“…This provides the opportunity to test, using the same system, the extent to which the in vitro test is predictive of in vivo genotoxic events. The adoption of the CBMN Cyt assay by the pharmaceutical industry 57,58,63 , its application in human biomonitoring of genotoxic exposures 24,60,61 and its increasing application in preventive medicine and nutrition 62,64,65 [66][67][68][69][70][71] .…”